The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Synthesis and Structure−Activity Relationship Study of Potent Trypanocidal Thio Semicarbazone Inhibitors of the Trypanosomal Cysteine Protease Cruzain
Open accessAbstract
American trypanosomiasis, or Chagas' disease, is the leading cause of heart disease in Latin America. Currently there is an urgent need to develop antitrypanosomal therapy due to the toxicity of existing agents and emerging drug resistance. A novel series of potent thio semicarbazone small-molecule inhibitors of the Trypanosoma cruzi cysteine protease cruzain have been identified. Some of these inhibitors have been shown to be trypanocidal. We initially discovered that 3'-bromopropiophenone thio semicarbazone (1i) inhibited cruzain and could cure mammalian cell cultures infected with T. cruzi. 3'-Bromopropiophenone thio semicarbazone showed no toxicity for mammalian cells at concentrations that were trypanocidal. Following this lead, more than 100 compounds were designed and synthesized. A specific structure-activity relationship (SAR) was established, and many potent analogues with IC(50) values in the low nanomolar range were identified. Eight additional analogues were trypanocidal in a cell culture assay, and this indicates that aryl thio semicarbazone is a productive scaffold for killing the parasites. Kinetic studies show that these are time-dependent inhibitors. Molecular modeling studies of the enzyme-inhibitor complex have led to a proposed mechanism of interaction as well as insight into the SAR of the thio semicarbazone series. The nonpeptide nature of this series, small size, and extremely low cost of production suggest this is a promising direction for the development of new antitrypanosome chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Substituent constants for correlation analysis in chemistry and biology
Hansch, C. H., & Leo, A. J. (1979) · Medical Entomology and Zoology · Cited by 2,903
Substituent Constants for Correlation Analysis in Chemistry and Biology.
Flynn, G. L. (1980) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600690938 · Cited by 2,820
Cysteine Proteases and Their Inhibitors
Otto, H.-H., & Schirmeister, T. (1997) · Chemical Reviews · doi:10.1021/cr950025u · Cited by 759
Critical evaluation of search algorithms for automated molecular docking and database screening
Ewing, T. J. A., & Kuntz, I. D. (1997) · Journal of Computational Chemistry · doi:10.1002/(sici)1096-987x(19970715)18:9<1175::aid-jcc6>3.0.co;2-o · Cited by 533
Vinyl Sulfones as Mechanism-Based Cysteine Protease Inhibitors
Palmer, J. T., Rasnick, D., Klaus, J. L., & Bromme, D. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00017a002 · Cited by 508
Cysteine Protease Inhibitors Cure an Experimental Trypanosoma cruzi Infection
Engel, J. C., Doyle, P. S., Hsieh, I., & McKerrow, J. H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.4.725 · Cited by 392
Self-citationTHE PROTEASES AND PATHOGENICITY OF PARASITIC PROTOZOA
McKerrow, J. H., Sun, E., Rosenthal, P. J., & Bouvier, J. (1993) · Annual Review of Microbiology · doi:10.1146/annurev.mi.47.100193.004133 · Cited by 385
Self-citationThe Crystal Structure of Cruzain: A Therapeutic Target for Chagas' Disease
McGrath, M. E., Eakin, A. E., Engel, J. C., McKerrow, J. H., Craik, C. S., & Fletterick, R. J. (1995) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.0137 · Cited by 269
Self-citation
Cited by
Specific chemotherapy of Chagas disease: controversies and advances
Urbina, J. A., & Docampo, R. (2003) · Trends in Parasitology · doi:10.1016/j.pt.2003.09.001 · Cited by 567
Specific chemotherapy of Chagas disease: Relevance, current limitations and new approaches
Urbina, J. A. (2010) · Acta Tropica · doi:10.1016/j.actatropica.2009.10.023 · Cited by 473
Anti-cancer palladium complexes: a focus on PdX2L2, palladacycles and related complexes
Kapdi, A. R., & Fairlamb, I. J. S. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00063c · Cited by 379
Drug discovery and development for neglected parasitic diseases
Renslo, A. R., & McKerrow, J. H. (2006) · Nature Chemical Biology · doi:10.1038/nchembio837 · Cited by 337
Self-citation
Metadata
- Authors
- Du, X., Guo, C., Hansell, E., Doyle, P. S., Caffrey, C. R., Holler, T. P., McKerrow, J. H., & Cohen, F. E.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2002-05-18
- Volume
- 45
- Issue
- 13
- Pages
- 2695-2707
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2086324268
- Cited by
- 381
- References
- 18
- FWCI
- 5.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.